- RecruitingPHASE3
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
This study is looking into a new medicine called prasinezumab for people with early-stage Parkinson's disease. We want to see if it's safe and helps improve symptoms compared to a dummy drug. Participants will be on a stable dose of existing Parkinson's medication.
For: Parkinson's DiseaseUnited States · Australia · Austria - Not yet recruitingPHASE2
Prevent Cognitive Decline in GBA-associated Parkinson's Disease
This study is testing a new medicine called prasinezumab to see if it can slow down memory and thinking problems in people with Parkinson's disease who have a specific genetic change. It involves monthly infusions over two years.
For: Parkinson's DiseaseFrance · Germany · Italy - Active not recruitingPHASE2
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease
This study is looking into a new treatment called prasinezumab for people in the early stages of Parkinson's disease. Researchers want to see if it's safe and helps improve symptoms. Participants will either receive the new medicine or a dummy treatment, called a placebo.
For: Parkinsons DiseaseUnited States · Austria · Canada